New Antipsychotic Strategies: Quetiapine and Risperidone vs. Fluphenazine in Treatment Resistant Schizophrenia

NCT00161018 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Maryland, Baltimore